The Rebound Effect: What Research Shows
Multiple studies have examined what happens to body weight after GLP-1 medications are discontinued. The findings are consistent and sobering. In the STEP 1 extension trial, participants who stopped semaglutide after 68 weeks regained approximately two-thirds of their lost weight within one year of stopping. Similar patterns have been observed with liraglutide and tirzepatide.
Why Weight Returns
The return of weight after stopping GLP-1 is not a personal failure — it is a physiological consequence of removing the drug. GLP-1 medications work by maintaining an artificial hormonal state of reduced appetite and improved metabolic signaling. When the medication is removed, appetite returns to its pre-medication level, hunger hormones rebound, and biological pressure toward the body's previous weight set point reasserts itself. This is why obesity medicine specialists increasingly view GLP-1 therapy as a long-term or lifelong treatment for many patients.
What Habits Make the Biggest Difference
Patients who maintain the most weight loss after stopping GLP-1 are those who built the strongest behavioral habits during treatment. The most protective habits are regular resistance training (which maintains elevated metabolism through preserved lean mass), consistently high protein intake (which maintains satiety and muscle), structured meal planning (which removes dependence on hunger cues as the primary eating trigger), and regular monitoring of body weight and food intake.
Planning for Stopping
If you are considering or planning to stop your GLP-1 medication, discuss it with your healthcare provider in advance. A gradual dose reduction rather than abrupt cessation may reduce the speed of appetite return. Intensifying your focus on protein intake and resistance training in the months before stopping gives your body the best foundation for maintaining results.